We are live on ! Find out more
IRD

Opus Genetics
IRD

31 hedge funds and large institutions have $3.2M invested in Opus Genetics in 2016 Q4 according to their latest regulatory filings, with 2 funds opening new positions, 5 increasing their positions, 10 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed

6% less funds holding

Funds holding: 33 → 31 (-2)

33% less first-time investments, than exits

New positions opened: 2 | Existing positions closed: 3

49% less capital invested

Capital invested by funds: $6.23M → $3.2M (-$3.03M)

50% less repeat investments, than reductions

Existing positions increased: 5 | Existing positions reduced: 10

Holders
31
Holders Change
-2
Holders Change %
-6.06%
% of All Funds
0.78%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
2
Increased
5
Reduced
10
Closed
3
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Renaissance Technologies
Renaissance Technologies
New York
+$287K
2
Wolverine Trading
Wolverine Trading
Illinois
+$6.75K
3
BMC
Benin Management Corp
Connecticut
+$3.34K
4
BFA
BlackRock Fund Advisors
California
+$2.12K
5
Wells Fargo
Wells Fargo
California
+$1.3K

Top Sellers

Rank Fund Capital Flow
1
AFM
Anson Funds Management
Texas
-$638K
2
Vanguard Group
Vanguard Group
Pennsylvania
-$448K
3
SM
Sabby Management
Florida
-$362K
4
CCM
Condor Capital Management
New Jersey
-$30K
5
VKH
Virtu KCG Holdings
New York
-$16.4K
Name Holding Trade Value Shares
Change 		Change in
Stake
SM
1
Sabby Management
Florida
$1.04M -$362K -4,454 -23%
AFM
2
Anson Funds Management
Texas
$768K -$638K -7,834 -41%
Renaissance Technologies
3
Renaissance Technologies
New York
$695K +$287K +3,530 +53%
Vanguard Group
4
Vanguard Group
Pennsylvania
$324K -$448K -5,501 -54%
Geode Capital Management
5
Geode Capital Management
Massachusetts
$130K – – –
BIT
6
BlackRock Institutional Trust
California
$47K – – –
Northern Trust
7
Northern Trust
Illinois
$31K +$1.06K +13 +3%
HVIA
8
Hudson Valley Investment Advisors
New York
$28K – – –
NFC
9
Northeast Financial Consultants
Connecticut
$21K – – –
Bank of New York Mellon
10
Bank of New York Mellon
New York
$17K -$1.22K -15 -6%
BMC
11
Benin Management Corp
Connecticut
$16K +$3.34K +41 +21%
TSS
12
Two Sigma Securities
New York
$15K -$12.9K -159 -41%
GC
13
Guggenheim Capital
Illinois
$10K – – –
BFA
14
BlackRock Fund Advisors
California
$8K +$2.12K +26 +28%
BA
15
BlackRock Advisors
Delaware
$6K – – –
Goldman Sachs
16
Goldman Sachs
New York
$6K – – –
State Street
17
State Street
Massachusetts
$6K – – –
NWM
18
Northwest Wealth Management
Iowa
$6K +$6.75K +83 New
Wolverine Trading
19
Wolverine Trading
Illinois
$6K +$6.75K +83 New
UBS Group
20
UBS Group
Switzerland
$4K -$5.13K -63 -50%
TRCT
21
Tower Research Capital (TRC)
New York
$4K -$2.93K -36 -36%
FHC
22
First Heartland Consultants
Missouri
$3K – – –
VKH
23
Virtu KCG Holdings
New York
$2K -$16.4K -201 -87%
ICOA
24
Investment Centers of America
North Dakota
$2K – – –
Cambridge Investment Research Advisors
25
Cambridge Investment Research Advisors
Iowa
$1K -$4.07K -50 -70%
1
2

IRD Hedge Fund Activity: Q4 2016 in Review

31 of the 4,000 institutional investors tracked by Wall St. Rank reported a position in Opus Genetics (IRD) for Q4 2016, worth a combined $3.2M — down 49% from $6.23M a quarter earlier.

Sellers outnumbered buyers: 3 funds closed out of IRD and 2 opened new positions — a net loss of 1 holder — while 10 trimmed existing stakes and 5 added.

The largest buyer was Renaissance Technologies, adding an estimated $287K. The largest seller was Anson Funds Management, cutting an estimated $638K.

  • 31 institutional investors held Opus Genetics (IRD) as of Q4 2016, down from 33 in Q3 2016.
  • Funds reported $3.2M of Opus Genetics stock for Q4 2016, down 49% quarter-over-quarter.
  • 2 funds opened new Opus Genetics positions in Q4 2016 and 3 closed out, a net change of -1 holder.
  • The largest Opus Genetics buyer in Q4 2016 was Renaissance Technologies, an estimated $287K added.
  • The largest Opus Genetics seller in Q4 2016 was Anson Funds Management, an estimated $638K sold.

Based on aggregated 13F filings for Q4 2016.